Drug
Myobloc
Myobloc: highest development phase Phase 3, developed by Supernus Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| MYOBLOC NCT02610868 | Phase 3 | Sialorrhea |
| MYOBLOC NCT01994109 | Phase 3 | Sialorrhea |
Latest
No recent events.
Follow Myobloc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.